Loading...
OTC Markets
Totals
Securities
12,214
Dollar Vol
$2.7B
Share Vol
3.1B
Trades
358,241

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

ZIVO
Zivo Bioscience, Inc.

Common Stock

13.25

0.00

0.00%

11.97 / 13.50 (200 x 1025)

Real-Time Best Bid & Ask: 05:00pm 07/18/2025
Delayed (15 Min) Trade Data: 12:00am 07/17/2025

Zivo Bioscience, Inc.

2125 Butterfield Road

Suite 100

Troy, MI 48084

Principal Executive Offices:

2125 Butterfield Drive

Suite 100

Troy, MI 48084

Business Description
Zivo Bioscience, Inc. is a Michigan-based biotech company engaged: 1) in the development and commercialization of therapeutic products containing bioactive compounds extracted or derived from its proprietary algal cultures for use as pharmaceuticals for treatment of disease in animals and humans; and 2) the development, manufacturing, marketing, and selling of nutritional products from or including our proprietary algal cultures for use as a food or a food additive to promote the general health of humans and animals.
Financial Reporting
Reporting Status
U.S. Reporting: SEC Reporting
Audited Financials
Audited
Latest Report
CIK
0001101026
Fiscal Year End
12/31
Company Officers & Contacts
John Bernard Payne
CEO

Mr. Payne was appointed to serve as a director of the Company in July, 2013. Mr. Payne is the President and CEO of Compassion-First Pet Hospitals and serves as the Chairman of the Board of Directors. He founded Compassion-First in 2014 and today, the family of specialty, general practice and emergency veterinary hospitals throughout the United States is dedicated to changing the veterinary landscape and elevating patient outcomes. With 44 hospitals across 14 states, Compassion-First has more than 3,000 employees and more than 230 board-certified specialists across a wide range of medical disciplines. Mr. Payne currently serves as the Chairman of the Board for American Humane and serves as the director of ZIVO Bioscience. He is on the Board of Regents at Ross University School of Medicine and at Ross University School of Veterinary Medicine. Prior to creating Compassion-First Mr. Payne served as a member of the Global Leadership Team for Mars Pet Care. He also served as the President and CEO of Banfield Pet Hospitals and served as the President and General Manager of Bayer Healthcare's North American Animal Health Division. Mr. Payne provides the Board of Directors with valuable insight and experience in the animal care and pharmaceutical fields.

Keith R Marchiando
CFO, Company Secretary

Board of Directors
Alison A. Cornell

Christopher Maggiore

Mr. Maggiore was appointed in August, 2013 to serve as a director of the Company. Mr. Maggiore is a successful entrepreneur and has been involved in real estate development, building and management of businesses for over 25 years. He currently owns and manages a portfolio of businesses and investments.

Nola E Masterson
Independent Director, Compensation Committee Member, Nominating Committee Member

Ms. Masterson was appointed in September 2014 to serve as a director of the Company. Since 1982, she has been the chief executive officer of Science Futures, Inc., an investment and advisory firm. Ms. Masterson is currently managing member and general partner of Science Futures LLC, I and II, which are venture capital funds invested in life science funds and companies. She was a member of the board of directors of Repros Therapeutics Inc. (sold to Allergan plc [NYSE: AGN] in January 2018) and served on the audit committee, nominating committee and the compensation committee at that company. Ms. Masterson was a biotechnology analyst on Wall Street, working with Drexel Burnham Lambert and Merrill Lynch, and is a co-founder and was CEO of Sequenom, Inc., a genetic analysis company located in San Diego, California and Hamburg, Germany. Ms. Masterson began her business career at Ames Company, a division of Bayer, and spent eight years at Millipore Corporation in sales and sales management and as Vice President of the Biotechnology Division. She received her Master's degree in Biological Sciences from George Washington University, and continued Ph.D. work at the University of Florida. Ms. Masterson provides us with the benefit of her extensive experience as an entrepreneur and an analyst on Wall Street, as well as her 40 years of investment advisory expertise and experiences in the life sciences industry.

John Bernard Payne
Independent Director

Mr. Payne was appointed to serve as a director of the Company in July, 2013. Mr. Payne is the President and CEO of Compassion-First Pet Hospitals and serves as the Chairman of the Board of Directors. He founded Compassion-First in 2014 and today, the family of specialty, general practice and emergency veterinary hospitals throughout the United States is dedicated to changing the veterinary landscape and elevating patient outcomes. With 44 hospitals across 14 states, Compassion-First has more than 3,000 employees and more than 230 board-certified specialists across a wide range of medical disciplines. Mr. Payne currently serves as the Chairman of the Board for American Humane and serves as the director of ZIVO Bioscience. He is on the Board of Regents at Ross University School of Medicine and at Ross University School of Veterinary Medicine. Prior to creating Compassion-First Mr. Payne served as a member of the Global Leadership Team for Mars Pet Care. He also served as the President and CEO of Banfield Pet Hospitals and served as the President and General Manager of Bayer Healthcare's North American Animal Health Division. Mr. Payne provides the Board of Directors with valuable insight and experience in the animal care and pharmaceutical fields.

Laith Larry Yaldoo

Other Company Insiders
Keith Maher
Armistice Capital
Laith Yaldoo
HEP Investments LLC
Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
BDO USA, LLP

1801 Market Street

Suite 1700

Philadelphia, PA 19103

Investor Relations/Marketing/Communications
Alliance Advisors, LLC

200 Broadacres Drive

Bloomfield, NJ 07003

Securities Counsel
Dickinson Wright PLLC - Ann Arbor, Michigan (United States)

350 S. Main Street, Suite 300

Ann Arbor, MI 48104

Profile Data
SIC - Industry Classification
2836 - Biological products, except diagnostic
Incorporation Information
NV, US, 2003
Employees
8 as of 09/30/2023
Shell
No
Products and Services

100% pure algal biomass dried and packaged as a food for human consumption. A product candidate for the treatment of coccidiosis in broiler chickens.

Company Facilities

The Company's headquarters is located in Bloomfield Hills, Michigan and also operates an algae cultivation lab in southern Florida.

Company Notes
Formerly=Health Enhancement Products, Inc. until 11-2014
Formerly=Western Glory Hole, Inc. until 12-03
Note=3-03 company is in the development stage
OTCQB Venture Market Logo
Joined OTCQB 01/2024
The Company Profile data was verified by the issuer within the previous 6 months.
This security is not a Penny Stock as defined in SEC Rule 240.3a51-1.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Securities
Other Zivo Bioscience, Inc. Securities
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.